Diagnostics

A Spanish team is hoping it can further validate promising early results using TCR characteristics to predict the success or failure of pre-surgery chemoimmunotherapy.

Researchers presented data at the meeting on biomarker-directed therapies and tests to characterize patients' responses to cancer treatment. 

Oncologists argued for and against comprehensive NGS at the point of diagnosis but agreed on the need to address quality and cost barriers first.